Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Retraction of "Structural Basis for Antagonism by Suramin of Heparin Binding to Vaccinia Complement Protein".

Ganesh VK, Muthuvel SK, Smith SA, Kotwal GJ, Murthy KHM.

Biochemistry. 2018 Oct 16;57(41):6043. doi: 10.1021/acs.biochem.8b00955. Epub 2018 Oct 3. No abstract available.

PMID:
30278609
2.

Significant upregulation of U1 and U4 spliceosomal snRNAs by ATP nanoliposomes explains acceleration of wound healing, due to increased pre-mRNA processing to functional mRNA.

Kotwal GJ, Martin MD, Chien S.

Nanomedicine. 2018 Jun;14(4):1289-1299. doi: 10.1016/j.nano.2018.03.003. Epub 2018 Apr 5.

PMID:
29627519
3.

Macrophage Differentiation in Normal and Accelerated Wound Healing.

Kotwal GJ, Chien S.

Results Probl Cell Differ. 2017;62:353-364. doi: 10.1007/978-3-319-54090-0_14. Review.

4.

Pivotal role of ATP in macrophages fast tracking wound repair and regeneration.

Kotwal GJ, Sarojini H, Chien S.

Wound Repair Regen. 2015 Sep;23(5):724-7. doi: 10.1111/wrr.12323. Epub 2015 Sep 14. Review.

PMID:
26053302
5.

Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases.

Kotwal GJ, Fernando N, Zhou J, Valter K.

Mol Immunol. 2014 Oct;61(2):204-9. doi: 10.1016/j.molimm.2014.06.022. Epub 2014 Jul 19. Review.

PMID:
25052409
6.

Environmental persistence and transfer of enteric viruses.

Kotwal G, Cannon JL.

Curr Opin Virol. 2014 Feb;4:37-43. doi: 10.1016/j.coviro.2013.12.003. Epub 2014 Jan 14. Review.

PMID:
24413147
7.

Sanitizer efficacy against murine norovirus, a surrogate for human norovirus, on stainless steel surfaces when using three application methods.

Bolton SL, Kotwal G, Harrison MA, Law SE, Harrison JA, Cannon JL.

Appl Environ Microbiol. 2013 Feb;79(4):1368-77. doi: 10.1128/AEM.02843-12. Epub 2012 Dec 21.

8.
9.

Human norovirus transfer to stainless steel and small fruits during handling.

Sharps CP, Kotwal G, Cannon JL.

J Food Prot. 2012 Aug;75(8):1437-46. doi: 10.4315/0362-028X.JFP-12-052.

PMID:
22856567
10.

Central nervous system distribution of the poxviral proteins after intranasal administration of proteins and titering of vaccinia virus in the brain after intracranial administration.

Kulkarni AP, Govender D, Kellaway LA, Kotwal GJ.

Methods Mol Biol. 2012;890:305-26. doi: 10.1007/978-1-61779-876-4_18.

PMID:
22688775
11.

Application of quartz crystal microbalance with dissipation monitoring technology for studying interactions of poxviral proteins with their ligands.

Kulkarni AP, Kellaway LA, Kotwal GJ.

Methods Mol Biol. 2012;890:289-303. doi: 10.1007/978-1-61779-876-4_17.

PMID:
22688774
12.

Characterization of poxvirus-encoded proteins that regulate innate immune signaling pathways.

Rus F, Morlock K, Silverman N, Pham N, Kotwal GJ, Marshall WL.

Methods Mol Biol. 2012;890:273-88. doi: 10.1007/978-1-61779-876-4_16.

PMID:
22688773
13.

Complement-initiated neuroinflammation and its role in early stage Alzheimer's disease. Commentary.

Kotwal GJ.

Curr Alzheimer Res. 2011 Feb;8(1):32-3. No abstract available.

PMID:
21294703
14.
15.
16.

Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins.

Sundararajan A, Ganapathy R, Huan L, Dunlap JR, Webby RJ, Kotwal GJ, Sangster MY.

Antiviral Res. 2010 Oct;88(1):1-9. doi: 10.1016/j.antiviral.2010.06.014. Epub 2010 Jul 14.

PMID:
20637243
17.
18.

Vaccinia virus complement control protein (VCP) improves kidney structure and function following ischemia/reperfusion injury in rats.

Ghebremariam YT, Engelbrecht G, Tyler M, Lotz Z, Govender D, Kotwal GJ, Kahn D.

J Surg Res. 2010 Apr;159(2):747-54. doi: 10.1016/j.jss.2009.04.049. Epub 2009 Jun 6.

PMID:
19691975
19.

Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.

Thorgersen EB, Pharo A, Haverson K, Axelsen AK, Gaustad P, Kotwal GJ, Sfyroera G, Mollnes TE.

Infect Immun. 2009 Feb;77(2):725-32. doi: 10.1128/IAI.01305-08. Epub 2008 Dec 1.

20.

Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus.

Mathew A, O'Bryan J, Marshall W, Kotwal GJ, Terajima M, Green S, Rothman AL, Ennis FA.

PLoS One. 2008 Oct 2;3(10):e3323. doi: 10.1371/journal.pone.0003323.

21.

Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.

Kulkarni AP, Pillay NS, Kellaway LA, Kotwal GJ.

Biogerontology. 2008 Dec;9(6):405-20. doi: 10.1007/s10522-008-9161-7. Epub 2008 Aug 5.

PMID:
18679819
22.

Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.

Pillay NS, Kellaway LA, Kotwal GJ.

Behav Brain Res. 2008 Oct 10;192(2):173-7. doi: 10.1016/j.bbr.2008.03.038. Epub 2008 Apr 7.

PMID:
18490064
24.

Vaccinia virus complement control protein significantly improves sensorimotor function recovery after severe head trauma.

Pillay NS, Kellaway LA, Kotwal GJ.

Brain Res. 2007 Jun 11;1153:158-65. Epub 2007 Mar 24.

PMID:
17467672
25.
26.

Antiviral activity of purified human breast milk mucin.

Habte HH, Kotwal GJ, Lotz ZE, Tyler MG, Abrahams M, Rodriques J, Kahn D, Mall AS.

Neonatology. 2007;92(2):96-104. Epub 2007 Mar 14.

PMID:
17361093
27.

Candidate inhibitors of porcine complement.

Thorgersen EB, Ghebremariam YT, Thurman JM, Fung M, Nielsen EW, Holers VM, Kotwal GJ, Mollnes TE.

Mol Immunol. 2007 Mar;44(8):1827-34. Epub 2006 Nov 15.

PMID:
17109963
28.

The structure of complement C3b provides insights into complement activation and regulation.

Abdul Ajees A, Gunasekaran K, Volanakis JE, Narayana SV, Kotwal GJ, Murthy HM.

Nature. 2006 Nov 9;444(7116):221-5. Epub 2006 Oct 15. Retraction in: Abdul Ajees A, Volanakis JE, Narayana SV. Nature. 2016 Apr 14;532(7598):268.

PMID:
17051152
30.

Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation.

Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, Rosengard AM, Kotwal GJ, Atkinson JP.

J Immunol. 2006 Mar 15;176(6):3725-34.

31.
32.

Herbal complement inhibitors in the treatment of neuroinflammation: future strategy for neuroprotection.

Kulkarni AP, Kellaway LA, Kotwal GJ.

Ann N Y Acad Sci. 2005 Nov;1056:413-29. Review.

PMID:
16387706
33.

Cloning and expression of a functionally active truncated N-glycosylated KSHV ORF4/KCP/kaposica in the methylotrophic yeast Pichia pastoris.

Gomes Pereira NA, Juliano MA, Carmona AK, Sturrock ED, Kotwal GJ.

Ann N Y Acad Sci. 2005 Nov;1056:388-404.

PMID:
16387704
34.
35.

Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral.

Kotwal GJ, Kaczmarek JN, Leivers S, Ghebremariam YT, Kulkarni AP, Bauer G, De Beer C, Preiser W, Mohamed AR.

Ann N Y Acad Sci. 2005 Nov;1056:293-302.

PMID:
16387696
36.

Intervention strategies and agents mediating the prevention of xenorejection.

Ghebremariam YT, Smith SA, Anderson JB, Kahn D, Kotwal GJ.

Ann N Y Acad Sci. 2005 Nov;1056:123-43. Review.

PMID:
16387682
38.

Curcumin inhibits the classical and the alternate pathways of complement activation.

Kulkarni AP, Ghebremariam YT, Kotwal GJ.

Ann N Y Acad Sci. 2005 Nov;1056:100-12.

PMID:
16387680
39.
40.

The vaccinia virus N1L protein influences cytokine secretion in vitro after infection.

Zhang Z, Abrahams MR, Hunt LA, Suttles J, Marshall W, Lahiri DK, Kotwal GJ.

Ann N Y Acad Sci. 2005 Nov;1056:69-86.

PMID:
16387678
41.

Vaccinia virus complement control protein ameliorates collagen-induced arthritic mice.

Jha P, Smith SA, Justus DE, Kotwal GJ.

Ann N Y Acad Sci. 2005 Nov;1056:55-68.

PMID:
16387677
42.

Vaccinia virus complement control protein diminishes formation of atherosclerotic lesions: complement is centrally involved in atherosclerotic disease.

Thorbjornsdottir P, Kolka R, Gunnarsson E, Bambir SH, Thorgeirsson G, Kotwal GJ, Arason GJ.

Ann N Y Acad Sci. 2005 Nov;1056:1-15.

PMID:
16387673
43.

Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein.

Ganesh VK, Muthuvel SK, Smith SA, Kotwal GJ, Murthy KH.

Biochemistry. 2005 Aug 16;44(32):10757-65. Retraction in: Biochemistry. 2018 Oct 16;57(41):6043.

PMID:
16086578
44.

Molecular mechanisms, emerging etiological insights and models to test potential therapeutic interventions in Alzheimer's disease.

Pillay NS, Kellaway LA, Kotwal GJ.

Curr Alzheimer Res. 2004 Nov;1(4):295-306. Review.

PMID:
15975058
45.

Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury.

Reynolds DN, Smith SA, Zhang YP, Mengsheng Q, Lahiri DK, Morassutti DJ, Shields CB, Kotwal GJ.

Ann N Y Acad Sci. 2004 Dec;1035:165-78.

PMID:
15681807
46.

Neuroprotection from complement-mediated inflammatory damage.

Kulkarni AP, Kellaway LA, Lahiri DK, Kotwal GJ.

Ann N Y Acad Sci. 2004 Dec;1035:147-64. Review.

PMID:
15681806
47.

Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain.

Billings B, Smith SA, Zhang Z, Lahiri DK, Kotwal GJ.

Ann N Y Acad Sci. 2004 Dec;1030:297-302.

PMID:
15659810
48.

Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.

DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, Zhang Z, Arvikar S, Latz E, Fitzgerald KA, Marshall WL.

J Biol Chem. 2004 Aug 27;279(35):36570-8. Epub 2004 Jun 23.

49.

Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.

Ganesh VK, Smith SA, Kotwal GJ, Murthy KH.

Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8924-9. Epub 2004 Jun 3. Retraction in: Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6965.

50.

Growing poxviruses and determining virus titer.

Kotwal GJ, Abrahams MR.

Methods Mol Biol. 2004;269:101-12. Review.

PMID:
15114010

Supplemental Content

Loading ...
Support Center